ArticleCureus2024

Sociodemographic Disparities in Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists Prescription Patterns Among Patients With Poorly Controlled Diabetes.

Daniel Antwi-Amoabeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.